{"id":"https://openalex.org/W7166187026","doi":"https://doi.org/10.1016/j.jval.2026.03.169","title":"CO74 MATCHING-ADJUSTED INDIRECT COMPARISON OF LUVOMETINIB VERSUS SELUMETINIB IN THE TREATMENT FOR PEDIATRIC PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 IN CHINA","display_name":"CO74 MATCHING-ADJUSTED INDIRECT COMPARISON OF LUVOMETINIB VERSUS SELUMETINIB IN THE TREATMENT FOR PEDIATRIC PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 IN CHINA","publication_year":2026,"publication_date":"2026-06-01","ids":{"openalex":"https://openalex.org/W7166187026","doi":"https://doi.org/10.1016/j.jval.2026.03.169"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2026.03.169","doi":"https://doi.org/10.1016/j.jval.2026.03.169","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jval.2026.03.169","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Chang Luo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I162868743","display_name":"Tianjin University","ror":"https://ror.org/012tb2g32","country_code":"CN","type":"education","lineage":["https://openalex.org/I162868743"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Chang Luo","raw_affiliation_strings":["Tianjin University, Tianjin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tianjin University, Tianjin, China","institution_ids":["https://openalex.org/I162868743"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lili Cheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405270815","display_name":"Jiangsu Pharmaceutical Association","ror":"https://ror.org/01c3kcb55","country_code":"CN","type":"nonprofit","lineage":["https://openalex.org/I4405270815"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lili Cheng","raw_affiliation_strings":["Jiangsu Provincial Pharmacy Association (JPPA), Nanjing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jiangsu Provincial Pharmacy Association (JPPA), Nanjing, China","institution_ids":["https://openalex.org/I4405270815"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5139412371","display_name":"Zigang Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104190","display_name":"Fosun Pharma (China)","ror":"https://ror.org/01kk11s67","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210104190"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zigang Li","raw_affiliation_strings":["Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Shanghai, China","institution_ids":["https://openalex.org/I4210104190"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100397440","display_name":"Yang Yang","orcid":"https://orcid.org/0000-0001-8147-7932","observed_orcids":["https://orcid.org/0000-0001-8147-7932"]},"institutions":[{"id":"https://openalex.org/I4210104190","display_name":"Fosun Pharma (China)","ror":"https://ror.org/01kk11s67","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210104190"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yang Yang","raw_affiliation_strings":["Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Shanghai, China","institution_ids":["https://openalex.org/I4210104190"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5139403461","display_name":"Xin Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104190","display_name":"Fosun Pharma (China)","ror":"https://ror.org/01kk11s67","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210104190"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xin Chen","raw_affiliation_strings":["Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Shanghai, China","institution_ids":["https://openalex.org/I4210104190"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032864526","display_name":"Keruo Zhou","orcid":"https://orcid.org/0009-0003-4523-9031","observed_orcids":["https://orcid.org/0009-0003-4523-9031"]},"institutions":[{"id":"https://openalex.org/I4210104190","display_name":"Fosun Pharma (China)","ror":"https://ror.org/01kk11s67","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210104190"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Keruo Zhou","raw_affiliation_strings":["Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Shanghai, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Shanghai, China","institution_ids":["https://openalex.org/I4210104190"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103283293","display_name":"Shitong Xie","orcid":"https://orcid.org/0000-0001-5454-3383","observed_orcids":["https://orcid.org/0000-0001-5454-3383"]},"institutions":[{"id":"https://openalex.org/I162868743","display_name":"Tianjin University","ror":"https://ror.org/012tb2g32","country_code":"CN","type":"education","lineage":["https://openalex.org/I162868743"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shitong Xie","raw_affiliation_strings":["Tianjin University, Tianjin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tianjin University, Tianjin, China","institution_ids":["https://openalex.org/I162868743"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"6","first_page":"S35","last_page":"S36"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11173","display_name":"Neurofibromatosis and Schwannoma Cases","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11173","display_name":"Neurofibromatosis and Schwannoma Cases","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neurofibromatosis-type-1","display_name":"neurofibromatosis type 1","score":0.9980000257492065},{"id":"https://openalex.org/keywords/selumetinib","display_name":"selumetinib","score":1.0},{"id":"https://openalex.org/keywords/pediatric-patients","display_name":"pediatric patients","score":0.777999997138977},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8429999947547913},{"id":"https://openalex.org/keywords/comparative-efficacy","display_name":"drug efficacy comparison","score":0.6259999871253967},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.8709999918937683},{"id":"https://openalex.org/keywords/matching-adjusted-indirect-comparison","display_name":"matching-adjusted indirect comparison","score":0.765999972820282},{"id":"https://openalex.org/keywords/china","display_name":"China","score":0.3700000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9165999889373779},{"id":"https://openalex.org/C2776087337","wikidata":"https://www.wikidata.org/wiki/Q7448840","display_name":"Selumetinib","level":5,"score":0.8481000065803528},{"id":"https://openalex.org/C2778984943","wikidata":"https://www.wikidata.org/wiki/Q847605","display_name":"Neurofibromatosis","level":2,"score":0.7985000014305115},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4569999873638153},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4503999948501587},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.38589999079704285},{"id":"https://openalex.org/C191935318","wikidata":"https://www.wikidata.org/wiki/Q148","display_name":"China","level":2,"score":0.3068999946117401},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2500999867916107},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.2475000023841858},{"id":"https://openalex.org/C2778102573","wikidata":"https://www.wikidata.org/wiki/Q7616509","display_name":"Neurofibromatosis type I","level":3,"score":0.24619999527931213}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jval.2026.03.169","doi":"https://doi.org/10.1016/j.jval.2026.03.169","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jval.2026.03.169","pdf_url":null,"source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7222796832","https://openalex.org/W4410804751","https://openalex.org/W4412432305","https://openalex.org/W4415554985","https://openalex.org/W4379338006","https://openalex.org/W4310754103","https://openalex.org/W4205228541","https://openalex.org/W4390706325","https://openalex.org/W4392606087","https://openalex.org/W4392595593"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-06-27T00:00:00"}